Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)

v3.23.3
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Health plan receivable, allowance for credit loss $ 150 $ 0
Related Party    
Accounts payable, other 45,900 33,000
Variable Interest Entity, Primary Beneficiary    
Assets to settle obligations 11,100 3,100
Liabilities without recourse to company assets $ 15,900 $ 9,900
Class A Common Stock    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 800,000,000 800,000,000
Common stock, shares issued (in shares) 114,249,000 41,579,000
Common stock, shares outstanding (in shares) 114,249,000 41,579,000
Class V Common Stock    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 205,000,000 205,000,000
Common stock, shares issued (in shares) 198,354,000 201,592,000
Common stock, shares outstanding (in shares) 198,354,000 201,592,000